Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics
Background Myasthenia gravis (MG) is an autoimmune disease usually caused by antibodies against the acetylcholine receptor (AChR-Abs), muscle-specific tyrosine kinase (MuSK-Abs), or low-density lipoprotein receptor-related protein 4 (LRP4-Abs). However, there are MG patients who do not ha...
Saved in:
| Main Authors: | Paula Raquel do Vale Pascoal Rodrigues, Cláudia Suemi Kamoi Kay, Renata Dal-Pra Ducci, Marco Antonio Takashi Utiumi, Otto Jesus Hernandez Fustes, Lineu Cesar Werneck, Paulo José Lorenzoni, Rosana Herminia Scola |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2024-01-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1779052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myasthenia gravis and thymus: long-term follow-up screening of thymectomized and non-thymectomized patients
by: Paulo Jose Lorenzoni, et al.
Published: (2013-07-01) -
Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
by: Paulo José Lorenzoni, et al.
Published: (2021-12-01) -
Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials
by: Paulo José LORENZONI, et al.
Published: (2020-03-01) -
Clinical characteristics and treatment outcomes of ocular myasthenia gravis at a tertiary eye care center in Eastern India
by: Thalluru Subhash, et al.
Published: (2025-06-01) -
The expectant management of a rare neonatal disease: transient neonatal myasthenia gravis
by: Farin Masra, et al.
Published: (2023-04-01)